Skip to Main Content

Author Details

Liz-Anne Lewsley
CRUK Clinical Trials Unit, University of Glasgow
2006
19
8
PMIDPaper TitleJournal TitlePublished Year
36928279Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.JAMA Oncol2023
37752102Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37542936Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis.Eur J Cancer2023
36980708CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.Cancers (Basel)2023
37474499The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
34446053Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).Radiat Oncol2021
34857017Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).Radiat Oncol2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
31922558Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis.JAMA Netw Open2020
33213530Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
29621378Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial.JAMA Oncol2018
30104763Copy number signatures and mutational processes in ovarian carcinoma.Nat Genet2018
29724815Biomarker Assessment of HR Deficiency, Tumor <i>BRCA1/2</i> Mutations, and <i>CCNE1</i> Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy.Mol Cancer Res2018
28359078Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.Br J Cancer2017
25454689Loading dose ibandronate versus standard oral ibandronate in patients with bone metastases from breast cancer.Clin Breast Cancer2015
25976296A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer - Anglo Celtic VII.Clin Oncol (R Coll Radiol)2015
23041585A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG.Ann Oncol2013
16404361SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer.Br J Cancer2006
  • 1 - 19 of 19

Recommended Authors

Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 13
George Au-Yeung
The University of Melbourne
Career Start Year 2012
Number of shared co-authors 24
Julia A Beaver
Center for Drug Evaluation and Research
Career Start Year 2007
Number of shared co-authors 0
Alan H Bryce
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 1
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2006
Number of shared co-authors 1
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 1
Shubham Pant
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Aditya Bardia
Massachusetts General Hospital Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Qian Shi
117902Beijing TongRen Hospital, Capital Medical University
Career Start Year 2004
Number of shared co-authors 3
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 3
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 14
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 1
Johann S de Bono
The Institute for Cancer Research
Career Start Year 1999
Number of shared co-authors 4
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Antonio Cubillo
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 0
Giuseppe Curigliano
University of Milan
Career Start Year 1996
Number of shared co-authors 5
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 2
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1993
Number of shared co-authors 1
David I Quinn
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 3
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 24
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 0
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 2
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 2
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 1
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 0
Ronald de Wit
Erasmus MC Cancer Institute
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Rosalind Glasspool
University of Glasgow
Co-authored papers 8
Iain A McNeish
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 8
Darren Ennis
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 7
Teodora Goranova
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
Anna M Piskorz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 4
Dilrini De Silva
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 4
Susana Banerjee
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 4
Isabelle Ray-Coquard
University Claude Bernard Lyon I
Co-authored papers 4
Euan A Stronach
Imperial College London
Co-authored papers 3
Samantha Hinsley
CRUK Glasgow Clinical Trials Unit, University of Glasgow
Co-authored papers 3
Florian Markowetz
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 3
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers 2
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 2
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
Helen Steed
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 2
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 2
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 2
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 2
Cyril B Gilks
University of British Columbia
Co-authored papers 2
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 2
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 2
Chloe Karpinskyj
Institute of Clinical Trials and Methodology, University College London
Co-authored papers 2
Valerie Rhenius
University of Cambridge
Co-authored papers 2
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 2
Michael E Carney
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 2
Release 1.2